Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs standard-dose quadrivalent influenza vaccine in adults ≥60 years in Japan
jRCT2051200067Completed
- Sponsor
- Sanofi
- Start
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of influenza vaccine in influenza (2 arms), sponsored by Sanofi. Primary endpoints: Post-vaccination GMTs of influenza vaccine antibodies and Seroconversion rate post-vaccination. Started Oct 2020; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2051200067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200067.